FDA panel supports approval of Asthmatx device for severe asthma

10/28/2009 | Wall Street Journal, The

An FDA panel voted 6-1 to recommend the approval of Asthmatx's Alair Bronchial Thermoplasty System as a first non-drug therapy for patients with severe asthma. The panel cited certain conditions for approval, such as the creation of a patient registry aimed at assessing the long-term safety and efficacy of the device.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN